We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+16.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.2B
AUM Growth
+$1.49B
(+9%)
Cap. Flow
-$841M
Cap. Flow
% of AUM
-4.62%
Top 10 Holdings %
Top 10 Hldgs %
18.93%
Holding
2,614
New
37
Increased
460
Reduced
567
Closed
1,419
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$38.7M |
| 2 |
Dell
DELL
|
+$26.1M |
| 3 |
Automatic Data Processing
ADP
|
+$24.2M |
| 4 |
Cognizant
CTSH
|
+$23.3M |
| 5 |
Regions Financial
RF
|
+$22.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$87.4M |
| 2 |
Lam Research
LRCX
|
+$69.8M |
| 3 |
Visa
V
|
+$62.2M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$55.7M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$41.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.75% |
| 2 | Healthcare | 13.19% |
| 3 | Financials | 11.7% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
FIVE9
FIVN
$2.12B
| $356K | ﹤0.01% |
2,042
+195
| +11% | +$29.7K |
|
|
VIVO
927
DELISTED
Meridian Bioscience Inc
VIVO
| $353K | ﹤0.01% |
18,938
+1,785
| +10% | +$33.3K |
|
928
Equinor
EQNR
$96.8B
| $352K | ﹤0.01% |
21,463
-6
| -0% | -$91 |
|
929
Bio-Techne
TECH
$11.2B
| $352K | ﹤0.01% |
4,440
-2,004
| -31% | -$145K |
|
930
BWX Technologies
BWXT
$15.2B
| $348K | ﹤0.01% |
5,782
-708
| -11% | -$40.8K |
|
931
Toyota
TM
$227B
| $347K | ﹤0.01% |
2,245
+157
| +8% | +$21.9K |
|
932
Teledyne Technologies
TDY
$30.1B
| $345K | ﹤0.01% |
882
-59
| -6% | -$21.2K |
|
933
Micron Technology
MU
$988B
| $343K | ﹤0.01% |
4,573
-20,310
| -82% | -$1.22M |
|
934
Sarepta Therapeutics
SRPT
$1.64B
| $343K | ﹤0.01% |
2,022
-104
| -5% | -$15.4K |
|
935
Editas Medicine
EDIT
$413M
| $339K | ﹤0.01% |
4,860
-37
| -0.8% | -$1.52K |
|
|
B
936
Barrick Mining
B
$63.2B
| $335K | ﹤0.01% |
14,810
-38,766
| -72% | -$982K |
|
937
Q2 Holdings
QTWO
$3.7B
| $332K | ﹤0.01% |
2,625
+130
| +5% | +$14K |
|
938
KKR & Co
KKR
$90.7B
| $329K | ﹤0.01% |
8,142
| – | – |
|
939
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.56B
| $328K | ﹤0.01% |
10,817
-134,388
| -93% | -$3.92M |
|
940
LeMaitre Vascular
LMAT
$2.34B
| $328K | ﹤0.01% |
8,120
+446
| +6% | +$15.9K |
|
941
NETSCOUT
NTCT
$2.91B
| $328K | ﹤0.01% |
11,987
-207
| -2% | -$4.95K |
|
942
Helios Technologies
HLIO
$2.57B
| $327K | ﹤0.01% |
6,155
+355
| +6% | +$16.7K |
|
943
Simon Property Group
SPG
$74.7B
| $327K | ﹤0.01% |
3,849
+128
| +3% | +$9.77K |
|
944
Freeport-McMoran
FCX
$91.2B
| $326K | ﹤0.01% |
12,574
-137
| -1% | -$2.85K |
|
945
WIX.com
WIX
$2.37B
| $322K | ﹤0.01% |
1,293
+212
| +20% | +$55.8K |
|
946
Diamondback Energy
FANG
$56.2B
| $321K | ﹤0.01% |
6,640
+5,902
| +800% | +$218K |
|
947
Rogers Corp
ROG
$2.18B
| $320K | ﹤0.01% |
2,062
+104
| +5% | +$13.8K |
|
948
Insight Enterprises
NSIT
$3.86B
| $319K | ﹤0.01% |
4,194
+269
| +7% | +$18.1K |
|
949
Deutsche Bank
DB
$69.6B
| $318K | ﹤0.01% |
29,263
-594
| -2% | -$6.12K |
|
950
Robert Half
RHI
$3.81B
| $318K | ﹤0.01% |
5,106
+120
| +2% | +$7.16K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q4 2020 Portfolio in Review
As of Q4 2020, Glenmede Trust held 2,614 positions worth $18.2B, up 9% from $16.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Glenmede Trust withdrew a net $841M in Q4 2020, closing 1,419 positions and reducing 567 holdings. Its most notable exit was H&R Block, an estimated $18.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in CryoPort worth $974K.
- Glenmede Trust's largest Q4 2020 buy was CryoPort: 22,210 shares worth $974K.
- Glenmede Trust added most to iShares Core S&P Small-Cap ETF in Q4 2020, an estimated $38.7M increase.
- Glenmede Trust's biggest Q4 2020 reduction was Progressive, cutting an estimated $87.4M.
- Glenmede Trust fully exited H&R Block in Q4 2020, selling an estimated $18.3M.
- Glenmede Trust's ten largest holdings make up 19% of its $18.2B portfolio in Q4 2020.
- Glenmede Trust opened 37 new positions and closed 1,419 in Q4 2020.
- Glenmede Trust's portfolio value rose 9% quarter-over-quarter to $18.2B.
Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.